Mona Sabharwal, PharmD, Executive Director, Pan-Canadian Oncology Drug Review
Ms. Sabharwal is the inaugural Executive Director of the pan-Canadian Oncology Drug Review (pCODR). She has worked in drug technology assessment and formulary management in both British Columbia and Ontario for more than 15 years. Before joining pCODR, she was Senior Manager for Drug Programs Management with the Ontario Ministry of Health and Long-Term Care. In this role, she had operational oversight of the drug submission and evaluation process for Ontario's six public drug programs, which serve more than 2.8 million people. In 2010, she launched Ontario's patient-evidence submission process to systematically solicit patient-centered perspectives on new drug therapies.